Rhythm is a biopharmaceutical company focused on developing and commercializing peptide therapeutics
Rhythm Pharmaceuticals has raised $175.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in July 2025.
Rhythm Pharmaceuticals's investors include New Enterprise Associates, OrbiMed, Pfizer Venture Investments, Third Rock Ventures, MPM Capital.
Rhythm Pharmaceuticals is headquartered in Boston, United States.
Rhythm is a biopharmaceutical company focused on developing and commercializing peptide therapeutics
Rhythm Pharmaceuticals is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Rhythm Pharmaceuticals — Funding & Investors." VCBacked, July 10, 2025, https://www.vcbacked.co/company/rhythm-pharmaceuticals. Accessed September 29, 2026.
VCBacked. (2025). Rhythm Pharmaceuticals — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/rhythm-pharmaceuticals
{{cite web |title=Rhythm Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/rhythm-pharmaceuticals |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated